Daily Cosmetic Research Analysis
Three impactful studies span cosmetic dermatology and oncologic aesthetics: a meta-analysis shows topical anesthetics, vibration, and cooling meaningfully reduce pain during facial botulinum toxin injections; a large post hoc analysis of Danish breast radiotherapy trials links tumor-bed boost (with or without repeat surgery) to higher 5-year breast induration without better cosmetic scores; and a biomaterials review outlines transdermal delivery materials that enhance polyphenol efficacy for whi
Summary
Three impactful studies span cosmetic dermatology and oncologic aesthetics: a meta-analysis shows topical anesthetics, vibration, and cooling meaningfully reduce pain during facial botulinum toxin injections; a large post hoc analysis of Danish breast radiotherapy trials links tumor-bed boost (with or without repeat surgery) to higher 5-year breast induration without better cosmetic scores; and a biomaterials review outlines transdermal delivery materials that enhance polyphenol efficacy for whitening and anti-aging.
Research Themes
- Pain control strategies for cosmetic neuromodulator injections
- Cosmetic toxicity trade-offs in breast-conserving therapy
- Transdermal biomaterials to enhance cosmeceutical polyphenol delivery
Selected Articles
1. Beyond the first cut: Impact of repeat surgery versus boost on breast induration-A post hoc analysis from the DBCG HYPO & PBI trials.
In a post hoc analysis of 1,919 patients from two DBCG phase III trials, tumor-bed boost increased the 5-year incidence of grade 2–3 breast induration compared with repeat surgery, without improving cosmetic outcomes. Repeat surgery alone carried a lower induration risk than boost, and RS-only versus boost-only showed no cosmetic differences.
Impact: Provides comparative long-term toxicity evidence informing the choice between repeat excision and tumor-bed boost after breast-conserving surgery, highlighting a clinically meaningful trade-off with aesthetic implications.
Clinical Implications: When margins are narrow, clinicians should carefully weigh the higher risk of breast induration with a boost against lack of cosmetic benefit relative to repeat surgery. Shared decision-making should incorporate patient priorities on late fibrosis/induration and appearance.
Key Findings
- Among 1,919 patients, 5-year grade 2–3 breast induration was 30.7% (RS+boost), 25.7% (boost only), 18.1% (RS only), and 13.5% (neither).
- Adjusted hazard ratios corroborated higher induration risk with boost versus RS.
- Cosmetic outcomes did not differ significantly between RS-only and boost-only groups at 3 and 5 years.
Methodological Strengths
- Large, multicenter dataset derived from two randomized phase III trials with standardized WBI regimens.
- Adjusted analyses and 5-year follow-up provide robust estimates of late toxicity.
Limitations
- Post hoc, non-randomized comparison of RS vs boost is subject to selection bias and residual confounding.
- Cosmetic assessment methods and generalizability beyond DBCG settings may be limited.
Future Directions: Prospective, propensity-matched or randomized strategies comparing RS and boost with standardized cosmetic and patient-reported outcomes; modeling trade-offs between local control and late toxicity.
PURPOSE: Following breast-conserving surgery (BCS), patients with narrow surgical margins frequently undergo repeat surgery (RS) or receive a tumour-bed boost to reduce the risk of local recurrence. Both interventions may increase the risk of late toxicity, including breast induration and adverse cosmetic outcomes. Comparative long-term data on these outcomes remain limited. This post hoc analysis assessed the impact of RS and tumour-bed boost on grade 2-3 breast induration and cosmetic outcomes in patients receiving whole-breast irradiation (WBI) for early-stage breast cancer or ductal carcinoma in situ (DCIS). RESULTS: The analysis included 1919 patients from two multicentre randomised phase III trials within the Danish Breast Cancer Group (DBCG): DBCG HYPO (WBI 50Gy/25fr versus 40Gy/15fr) and DBCG PBI (40Gy/15fr, WBI versus partial breast irradiation (PBI)). Of these, 303 patients (16 %) underwent RS and 220 patients (11 %) received a boost. Patients were categorised into four groups: 'RS and boost', 'boost only', 'RS only', and 'No RS, no boost'. At 5 years, the cumulative incidence of grade 2-3 breast induration was highest in the 'RS and boost' group (30.7 %), followed by 'boost only' (25.7 %), 'RS only' (18.1 %), and 'No RS, no boost' (13.5 %). Adjusted hazard ratios confirmed this pattern. No significant differences in cosmetic outcomes were observed between the 'RS only' and 'boost only' groups at 3 or 5 years. CONCLUSIONS: A tumour-bed boost was associated with a higher risk of breast induration compared to RS, with no difference in cosmetic outcome.
2. Impact of topical analgesia on injection pain perception in facial botulinum toxin injections: A systematic review and meta-analysis.
Across 11 RCTs and 3 controlled studies (n=472), topical anesthetic gel/spray, vibration, and cooling significantly reduced facial botulinum toxin injection pain versus no analgesia/placebo, with a pooled VAS effect size of −1.20 (CI −1.69 to −0.70). Study quality was low-to-moderate with heterogeneity.
Impact: Addresses a frequent patient-centered outcome in aesthetic and functional neuromodulator practice, providing quantitative guidance on effective non-invasive analgesia strategies.
Clinical Implications: Use topical anesthetic gel/spray, vibration, or cooling to reduce injection pain for facial botulinum toxin procedures. Standardize pain assessment and consider modality choice based on availability, cost, and patient preference.
Key Findings
- Meta-analysis of 11 RCTs and 3 controlled studies (n=472) showed significant VAS pain reduction with anesthetic gel/spray, vibration, and cooling versus no analgesia/placebo.
- Pooled overall effect size favored intervention: −1.20 (95% CI −1.69 to −0.70).
- GRADE-based quality was low to moderate; heterogeneity, small sample sizes, and limited head-to-head comparisons were noted.
Methodological Strengths
- Predefined inclusion/exclusion criteria across three databases and quantitative synthesis with forest plots.
- Inclusion of multiple non-pharmacologic and pharmacologic topical modalities relevant to clinical practice.
Limitations
- Overall study quality low-to-moderate with clinical and methodological heterogeneity.
- Few direct head-to-head comparisons between analgesic modalities; small sample sizes.
Future Directions: Conduct adequately powered RCTs directly comparing analgesic modalities and combinations with standardized VAS and patient-reported outcomes, cost-effectiveness, and safety.
This systematic review compared the effect of various topical analgesics on botulinum toxin injection pain perception. Data search was conducted in PubMed, Web of Science and the Cochrane Library up to 30 November 2024. Inclusion criteria were (1) research articles in English, Dutch, French or German; (2) study population with adults ≥ 18 years; (3) facial botulinum toxin injections for cosmetic and/or functional indications; (4) comparison of different types of topical analgesia or topical analgesia with no analgesia applied and (5) inclusion of injection pain measurement. Exclusion criteria included (1) articles comparing solvent variations; (2) systematic reviews and meta-analyses and (3) injection areas other than the face. Eleven RCTs (randomised controlled trials) and 3 controlled, non-randomised studies with a total of 472 patients were included. An evidence profile table showed that the quality of the studies according to the grading of recommendations, assessment, development and evaluation guidelines was in the low and moderate categories. A forest plot was used to display the results of pooled VAS (Visual Analogue Scale) scores for comparison after topical analgesia versus no analgesia. A statistically significant reduction in pain scores was observed with an anaesthetic gel or spray, vibration stimulus and cooling compared to no analgesia or placebo. Results can be pooled to an overall effect size of -1.20 in favour of the intervention (CI: -1.69, -0.70). This systematic review was limited owing to bias, indirectness, imprecision, clinical and methodological heterogeneity, small study groups and few studies comparing different types of topical analgesia. Further research is needed to determine the optimal type of analgesia prior to botulinum toxin injections.
3. Transdermal delivery materials for polyphenols in whitening and anti-aging applications.
This review synthesizes how phospholipids, neutral esters, and polymers enable transdermal delivery of polyphenols by improving solubility, stability, release control, and skin interactions, thereby enhancing whitening and anti-aging efficacy. It mechanistically links TYR/MITF modulation and anti-ROS/MMP effects with material-driven skin penetration and retention.
Impact: Provides material-centric design principles for improving bioavailability and performance of safer cosmeceuticals, addressing key barriers that limit polyphenol efficacy.
Clinical Implications: Guides formulation scientists toward delivery systems that improve skin penetration and retention of polyphenols, potentially enabling longer-term, better-tolerated whitening and anti-aging products.
Key Findings
- Polyphenols act via TYR/MITF modulation and by suppressing UV-induced ROS and MMPs, supporting whitening and anti-aging effects.
- Poor solubility, low stability, and limited skin permeability constrain cosmetic performance.
- Phospholipids, neutral esters, and polymers enhance solubility, stability, controlled release, and skin interaction (barrier modulation, hydration, occlusion, adhesion) to increase retention/penetration.
Methodological Strengths
- Integrates mechanistic pathways with material properties to inform rational delivery design.
- Focused synthesis on three key material classes with clear structure–function considerations.
Limitations
- Narrative review without formal PRISMA methodology or quantitative synthesis.
- Limited translation to clinical endpoints; many data from preclinical or formulation studies.
Future Directions: Head-to-head clinical trials of delivery systems, standardized skin penetration/retention assays, long-term safety, and regulatory frameworks for cosmeceutical claims.
Polyphenols have emerged as promising agents in the field of skin whitening and anti-aging due to their natural origin, excellent biocompatibility, and ability to modulate multiple biological pathways. Mechanistically, polyphenols inhibit melanin production through modulation of the tyrosinase (TYR) and microphthalmia-associated transcription factor (MITF) signaling pathways, and preserve collagen structure and dermal integrity by suppressing ultraviolet (UV)-induced reactive oxygen species (ROS) generation and matrix metalloproteinases (MMPs) expression. Unlike conventional agents such as hydroquinone, kojic acid, and tretinoin, which easily cause skin irritation and allergy, polyphenols are associated with fewer side effects, broader biological activities, and better suitability for long-term transdermal use. Despite these advantages, the application of polyphenols in cosmetics is hindered by intrinsic limitations, including poor aqueous solubility, low chemical stability under physiological conditions, and inadequate skin permeability, which significantly restrict its bioavailability and cosmetic performance. To address these issues, researchers have constructed a variety of delivery systems through exploiting the merits of delivery materials, which not only enhance the physicochemical properties of polyphenols, such as solubility, stability, and controlled release, but also improve the interaction with skin physiological features including skin barrier modulation, skin hydration, skin occlusion, and skin adhesion. These properties can increase skin retention and penetration for more precise delivery and significantly improve whitening and anti-aging effects. In this review, we first give a brief introduction to polyphenols for whitening and anti-aging applications. We then focus on the latest applications of three types of materials, namely phospholipids, neutral esters, and polymers, in transdermal delivery systems of polyphenols for skin whitening and anti-aging. Lastly, we discuss the important roles of delivery materials in improving transdermal delivery performance to provide valuable insights into the design and development of more effective delivery systems.